The RevoLix 200 provides some of the highest available Thulium wattage (200) for the treatment of benign prostatic hyperplasia (BPH). It has a wavelength of 2013nm, which targets the water in tissue to provide superior vaporization, cutting and hemostasis of the prostate. As a result, the RevoLix 200 leads to less postoperative pain, less necrotic tissue generated and faster patient turn around and recovery. In addition to BPH, the RevoLix 200 can also be used for strictures, bladder tumors and more. End and side fire fibers are both available for the RevoLix 200, and the fibers can be used in contact and non-contact with tissue.